1 week ago
6
Soumya Eswaran
Tue, April 14, 2026 astatine 8:22 AM CDT 3 min read
Vltava Fund's Q1 2026 letter, titled “Sport and Investing,” compares sports and investing, highlighting cardinal marketplace themes. A transcript of the missive is disposable to download here. January focused connected artificial intelligence, followed by the Iran war, which impacted businesses successful the short- and long-term. Later, backstage recognition gained attraction amid rising involvement rates, defaults, and liquidity issues. Market volatility increased, creating much opportunities and prompting greater enactment to make worth for the portfolio. Please reappraisal the Fund’s apical 5 holdings to summation insights into their cardinal selections for 2026.
In its first-quarter 2026 capitalist letter, Vltava Fund highlighted Novo Nordisk A/S (NYSE:NVO). Novo Nordisk A/S (NYSE:NVO) is simply a starring pharmaceutical institution engaged successful the probe and development, manufacture, and organisation of pharmaceutical products. On April 13, 2026, Novo Nordisk A/S (NYSE:NVO) closed astatine $37.98 per share. One-month instrumentality of Novo Nordisk A/S (NYSE:NVO) was -1.17%, and its shares mislaid 41.11% implicit the past 52 weeks. Novo Nordisk A/S (NYSE:NVO) has a marketplace capitalization of $169.1 billion.
Vltava Fund stated the pursuing regarding Novo Nordisk A/S (NYSE:NVO) successful its Q1 2026 capitalist letter:
"We sold 2 banal positions: Novo Nordisk A/S (NYSE:NVO) and United Rentals. We had acquired astir of our presumption successful Novo Nordisk past summertime aft the stock’s important year-over-year terms diminution was compounded by the largest single-day driblet successful its history. We bought the shares comparatively cheaply; their terms past began gradually to rise, but, astatine the aforesaid time, Novo Nordisk’s fiscal outlook for the coming years continued to deteriorate. This yet dominated our thinking, and we sold the shares. We came to recognize that our quality to foretell the company’s aboriginal improvement was truthful anemic that continuing to clasp the shares would magnitude to axenic speculation. We bash not put wealth successful this mode and preferred to determination it to wherever visibility into aboriginal developments is overmuch greater."
Novo Nordisk A/S (NYSE:NVO) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 55 hedge money portfolios held Novo Nordisk A/S (NYSE:NVO) astatine the extremity of the 4th quarter, up from 50 successful the erstwhile quarter. While we admit the imaginable of Novo Nordisk A/S (NYSE:NVO) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
English (CA) · 
English (US) · 
Spanish (MX) ·